COSMO Pharmaceuticals Forecast, price target & analysts
COSMO Pharmaceuticals Target price 2025 - Analyst rating & recommendation
COSMO Pharmaceuticals Classifications & Recommendation:
COSMO Pharmaceuticals Price Target
| Target Price | CHF93.78 |
| Price | CHF60.00 |
| Potential |
56.30%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a COSMO Pharmaceuticals price target 2026.
The average COSMO Pharmaceuticals target price is CHF93.78.
This is
56.30%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend COSMO Pharmaceuticals to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the COSMO Pharmaceuticals stock has an average upside potential 2026 of
56.30%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million CHF | 250.61 | 97.65 |
| 187.56% | 61.03% | |
| EBITDA Margin | 56.51% | 22.06% |
| 23,553.35% | 60.97% | |
| Net Margin | 49.94% | 3.22% |
| 529.66% | 93.55% |
2 Analysts have issued a sales forecast COSMO Pharmaceuticals 2025 . The average COSMO Pharmaceuticals sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an COSMO Pharmaceuticals EBITDA forecast 2025. The average COSMO Pharmaceuticals EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast COSMO Pharmaceuticals 2025 . The average COSMO Pharmaceuticals net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 7.65 | 0.20 |
| 1,314.29% | 97.39% | |
| P/E | 305.70 | |
| EV/Sales | 9.03 |
1 Analysts have issued a COSMO Pharmaceuticals forecast for earnings per share. The average COSMO Pharmaceuticals EPS is
This results in the following potential growth metrics and future valuations:
COSMO Pharmaceuticals...
Current COSMO Pharmaceuticals Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Mar 06 2025 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Jan 09 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Mar 06 2025 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Jan 09 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 18 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
